Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam A Awad

Showing results (191-200 of 199) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 199 results.
Nature|April 28, 2021
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanismAileen A Ren, Daniel A Snellings, Yourong S Su, et al.
The Journal of Experimental Medicine|July 11, 2020
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versicanCourtney C Hong, Alan T Tang, Matthew R Detter, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Science Immunology|April 23, 2021
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhageMichael H Askenase, Brittany A Goods, Hannah E Beatty, et al.
Science Translational Medicine|November 29, 2019
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformationAlan T Tang, Katie R Sullivan, Courtney C Hong, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Stroke|May 6, 2022
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-AnalysisJoji B Kuramatsu, Stefan T Gerner, Wendy Ziai, et al.
Pageof 20

Showing results (191-200 of 199) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 199 results.
Nature|April 28, 2021
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanismAileen A Ren, Daniel A Snellings, Yourong S Su, et al.
The Journal of Experimental Medicine|July 11, 2020
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versicanCourtney C Hong, Alan T Tang, Matthew R Detter, et al.
Stroke|December 22, 2023
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Medrxiv : the Preprint Server for Health Sciences|June 19, 2023
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial ModelingStephanie Hage, Serena Kinkade, Romuald Girard, et al.
Science Immunology|April 23, 2021
Longitudinal transcriptomics define the stages of myeloid activation in the living human brain after intracerebral hemorrhageMichael H Askenase, Brittany A Goods, Hannah E Beatty, et al.
Science Translational Medicine|November 29, 2019
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformationAlan T Tang, Katie R Sullivan, Courtney C Hong, et al.
Lancet (London, England)|January 14, 2017
Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trialDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Lancet (London, England)|February 12, 2019
Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trialDaniel F Hanley, Richard E Thompson, Michael Rosenblum, et al.
Stroke|May 6, 2022
Association of Intraventricular Fibrinolysis With Clinical Outcomes in Intracerebral Hemorrhage: An Individual Participant Data Meta-AnalysisJoji B Kuramatsu, Stefan T Gerner, Wendy Ziai, et al.
Pageof 20